Crown Advisors Management’s DexCom DXCM Stock Holding History

Crown Advisors Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,000	Closed	-$566K	–	43
2024 Q2	$566K	Hold	5,000	–	–	0.36%	40
2024 Q1	$693K	Hold	5,000	–	–	0.42%	41
2023 Q4	$620K	Sell	5,000 -5,000	-50%	-$511K	0.42%	42
2023 Q3	$933K	Buy	+10,000	New	+$1.13M	0.66%	40
2020 Q4	–	Sell	-24,000	Closed	-$2.47M	–	38
2020 Q3	$2.47M	Sell	24,000 -8,000	-25%	-$836K	1.61%	28
2020 Q2	$3.24M	Buy	+32,000	New	+$2.86M	2.22%	22

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Crown Advisors Management's DXCM Position: Q3 2024 in Review

Crown Advisors Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 5,000 shares — an estimated $566K sold.

Crown Advisors Management first reported a position in DXCM in Q2 2020 and held it in 6 quarters. The position peaked at $3.24M in Q2 2020. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Crown Advisors Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Crown Advisors Management sold 5,000 DexCom shares in Q3 2024, an estimated $566K.
Crown Advisors Management first reported a position in DexCom in Q2 2020 and held it in 6 quarters.
Crown Advisors Management's DexCom position peaked at $3.24M in Q2 2020.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Crown Advisors Management's 13F filing for Q3 2024, filed 12 Nov 2024.